13F

Stock

Crispr Therapeutics Ag

CRSP · held by 3 managers

Reported value

$24.3M

Holders

3

+0 new · −0 exited

Holders’ est. mark

−$4.26M

Price effect on 3 books still in the name

Largest holder

$23.2M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC510.8K$23.2M−$4.01MAdded$2.24M
Norris Financial Group, LLC14.4K$655.9K−$130KCut−$23.1K
Marex Group plc10.7K$484.7K−$114.8KCut−$161.9K

Positions as of Q3 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.